NASDAQ:INCR
Delisted
INC Research Holdings Stock News
$40.50
+0 (+0%)
At Close: Jan 22, 2018
InterCure Ltd. (INCR) Q4 2022 Earnings Call Transcript
06:56pm, Tuesday, 04'th Apr 2023
InterCure Ltd. (NASDAQ:INCR ) Q4 2022 Earnings Conference Call April 4, 2023 4:30 PM ET Company Participants Alexander Rabinovitch - CEO & Director Amos Cohen - CFO Conference Call Participants Vivien
InterCure Reschedules 2022 Full Year Results Conference Call
03:27pm, Monday, 03'rd Apr 2023
NEW YORK, TORONTO, and HERZLIYA, Israel, April 03, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) announced today th
InterCure: Why The Company Is Grossly Undervalued By Wall Street
12:22pm, Friday, 20'th Jan 2023
InterCure earned CAD$39 million in Q3 2022, up 61.2% from the previous year. Moreover, at the end of Q4 2022, the total number of licensed patients using cannabis for medical purposes in Israel was 12
Cannabis Is A Long-Term Play (Podcast Transcript)
06:30am, Monday, 09'th Jan 2023
Negative conditions are crashing down all around investors. Make sure companies in your portfolio will survive.
Buy InterCure To Ride The Coming Wave Of Global Cannabis Growth
11:42pm, Tuesday, 08'th Nov 2022
Legal cannabis around the world is just beginning but will surpass that of North America. Europe is one of the largest growth markets for companies in global cannabis.
InterCure: Highlighting A Profitable Israeli Cannabis Operator
12:11pm, Tuesday, 25'th Oct 2022
InterCure is the leading cannabis operator in Israel. Israel is currently a medical market, with recreational legalization expected to occur over the coming years.
InterCure: A Leader In Global Cannabis
05:25pm, Tuesday, 06'th Sep 2022
The global cannabis market will eventually be far bigger than North America. InterCure is a leading company in global pharmaceutical cannabis.
InterCure Ltd (INCR) CEO Alexander Rabinovitch on Q2 2022 Results - Earnings Call Transcript
02:11pm, Tuesday, 16'th Aug 2022
InterCure Ltd (NASDAQ:INCR ) Q2 2022 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Adam Haliva - Communications Officer Alexander Rabinovitch - CEO & Director Amos Cohen - C
5 Cannabis Stocks You Don't Want to Hit 'Snooze' On
02:51pm, Friday, 22'nd Jul 2022
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will co
Buying Into A Down Market (Podcast Transcript)
08:30am, Thursday, 16'th Jun 2022
Ted Waller returns to discuss staying bullish but getting more realistic about the cannabis industry. Limited growth rates, margin compression and the need to keep our emotions out of investing.
InterCure Is Growing In The Massive Global Cannabis Market
01:06pm, Tuesday, 07'th Jun 2022
Most of cannabis industry growth will occur outside North America. The road to global growth starts with medical cannabis.
The Holiday-Shortened Week Didn't Stop These 8 Cannabis Stocks
11:40am, Friday, 03'rd Jun 2022
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will co
Still A Lot More Work To Do In The Cannabis Industry (Podcast Transcript)
09:42am, Monday, 23'rd May 2022
Michael Auerbach, Chairman of The Parent Company, updates us on the growth that hasn't shown up the way we expected. InterCure and the Israeli market.
What Happened With These 11 Cannabis Stocks This Week?
10:32am, Friday, 20'th May 2022
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will co
InterCure Ltd.'s (INCR) CEO Alex Rabinovitch on Q1 2022 Results - Earnings Call Transcript
05:06pm, Tuesday, 17'th May 2022
InterCure Ltd. (NASDAQ:INCR ) Q1 2022 Earnings Conference Call May 17, 2022 8:00 AM ET Company Participants Adam Haliva - Communications Officer Alex Rabinovitch - Chief Executive Officer Amos Cohen -
